NovoCure (NVCR) just unveiled an update.
NovoCure Limited is undergoing significant leadership changes, as CEO Asaf Danziger steps down to become a Senior Advisor and Director, while CFO Ashley Cordova is set to take the CEO position on January 1, 2025. COO Wilco Groenhuysen also resigned, transitioning into a Senior Advisor role. These shifts come with new contractual arrangements and severance terms, reflecting the evolving management structure within the company.
For detailed information about NVCR stock, go to TipRanks’ Stock Analysis page.
